Evolent Health
EVH
EVH
218 hedge funds and large institutions have $2.78B invested in Evolent Health in 2022 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 87 increasing their positions, 75 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
5% more funds holding
Funds holding: 207 → 218 (+11)
0.53% more ownership
Funds ownership: 94.74% → 95.26% (+0.53%)
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
Holders
218
Holding in Top 10
7
Calls
$9.86M
Puts
$6.97M
Top Buyers
| 1 | +$32M | |
| 2 | +$25.1M | |
| 3 | +$18.8M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$18.1M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$17.6M |
Top Sellers
| 1 | -$26.3M | |
| 2 | -$23.3M | |
| 3 | -$22.1M | |
| 4 |
GLA
Great Lakes Advisors
Chicago,
Illinois
|
-$21.8M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$15.2M |